Oman Makes Medical History with First CAR-T Therapy in the Region

Strategic Insights -

The University Medical City in Oman has achieved a medical milestone by successfully implementing the first Chimeric Antigen Receptor T-cell (CAR-T) therapy in the Sultanate. This pioneering treatment, utilizing national medical personnel and international partnerships, marks a significant step towards providing advanced and precision treatments for blood cancer patients. CAR-T cell therapy has shown remarkable response rates in patients with B-cell Acute Lymphoblastic Leukemia (B-ALL) and Diffuse Large B-cell Lymphoma (DLBCL), particularly for those unresponsive to conventional therapies. The achievement reflects the rapid advancement of Oman's healthcare sector in biomedical innovation and offers hope to patients and their families.

Key Takeaways:

  • The University Medical City in Oman has successfully implemented the first CAR-T therapy in the region, utilizing national medical personnel and international partnerships.
  • CAR-T cell therapy has shown remarkable response rates in patients with B-cell Acute Lymphoblastic Leukemia (B-ALL) and Diffuse Large B-cell Lymphoma (DLBCL).
  • The treatment was implemented through collaboration between the lymphoma and myeloid oncology team, bone marrow transplantation, and cellular therapy at the National Center for Blood Diseases and Bone Marrow Transplantation.
  • The goal is to localize cutting-edge medical technologies, establish a national center for advanced therapies, and translate research into clinical applications.
  • The implementation of CAR-T therapy marks a step towards medical self-sufficiency and cost reduction compared to overseas referrals.
  • Oman is investing in national workforce training and global collaborations to ensure compliance with international standards.

Statistics:

  • CAR-T therapy has shown response rates of up to 80% in patients with B-ALL and DLBCL (Source: [1] Oman News Agency)
  • The treatment has previously been limited to select international centers (Source: [2] Represented by the National Center for the Treatment of Blood Diseases and Bone Marrow Transplantation)
  • Oman has invested in substantial training for its national workforce to ensure compliance with international standards (Source: [3] Director of the Overseas Treatment Department at the Ministry of Health)

Sources:

  • Oman News Agency - 18 Aug 2025
  • Represented by the National Center for the Treatment of Blood Diseases and Bone Marrow Transplantation
  • Ministry of Health's Overseas Treatment Department